Acute effects of partial positive allosteric GABAA receptor modulation by GT-002 on psychophysiological and cognitive measures: protocol for the TOTEMS phase II trial targeting cognitive impairment associated with schizophrenia

Thomas Hartwig Siebner, Karen Sandø Ambrosen, Cecilie Koldbæk Lemvigh, Christine Natasha Ryan, Mikkel Erlang Sørensen, María Hernández-Lorca, Birte Yding Glenthøj, Kit Melissa Larsen, Michael-Robin Witt, Bob Oranje, Bjørn Hylsebeck Ebdrup

Open source

DOI: 10.3389/fpsyt.2025.1656792
Published: 2025-11-25
Container: Frontiers in Psychiatry
Publisher: Frontiers Media SA
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3389/fpsyt.2025.1656792,
  title = {Acute effects of partial positive allosteric GABAA receptor modulation by GT-002 on psychophysiological and cognitive measures: protocol for the TOTEMS phase II trial targeting cognitive impairment associated with schizophrenia},
  author = {Thomas Hartwig Siebner and Karen Sandø Ambrosen and Cecilie Koldbæk Lemvigh and Christine Natasha Ryan and Mikkel Erlang Sørensen and María Hernández-Lorca and Birte Yding Glenthøj and Kit Melissa Larsen and Michael-Robin Witt and Bob Oranje and Bjørn Hylsebeck Ebdrup},
  year = {2025},
  journal = {Frontiers in Psychiatry},
  doi = {10.3389/fpsyt.2025.1656792},
  url = {https://doi.org/10.3389/fpsyt.2025.1656792}
}

RIS

TY  - JOUR
TI  - Acute effects of partial positive allosteric GABAA receptor modulation by GT-002 on psychophysiological and cognitive measures: protocol for the TOTEMS phase II trial targeting cognitive impairment associated with schizophrenia
AU  - Thomas Hartwig Siebner
AU  - Karen Sandø Ambrosen
AU  - Cecilie Koldbæk Lemvigh
AU  - Christine Natasha Ryan
AU  - Mikkel Erlang Sørensen
AU  - María Hernández-Lorca
AU  - Birte Yding Glenthøj
AU  - Kit Melissa Larsen
AU  - Michael-Robin Witt
AU  - Bob Oranje
AU  - Bjørn Hylsebeck Ebdrup
PY  - 2025
JO  - Frontiers in Psychiatry
DO  - 10.3389/fpsyt.2025.1656792
UR  - https://doi.org/10.3389/fpsyt.2025.1656792
ER  -

APA

Siebner, T. H., Ambrosen, K. S., Lemvigh, C. K., Ryan, C. N., Sørensen, M. E., Hernández-Lorca, M., Glenthøj, B. Y., Larsen, K. M., Witt, M., Oranje, B., & Ebdrup, B. H. (2025). Acute effects of partial positive allosteric GABAA receptor modulation by GT-002 on psychophysiological and cognitive measures: protocol for the TOTEMS phase II trial targeting cognitive impairment associated with schizophrenia. Frontiers in Psychiatry. https://doi.org/10.3389/fpsyt.2025.1656792

Source records

crossref · retrieved 2026-09-26T13:09:17.697Z